Acquired resistance to targeted therapies in advanced non-small cell lung cancer: new strategies and new agents

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages

  West, Howard ^a   Oxnard, Geoffrey R ^a   Doebele, Robert C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; DRUG DESIGN; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN; LUNG NEOPLASMS; METABOLISM; MOLECULARLY TARGETED THERAPY; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; MUTATION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84946240088     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.e272     Document Type: Review

References (0)